News

Business Insider7y
Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
HOLZKIRCHEN, Germany, Feb. 13, 2018 /PRNewswire/ -- Sandoz, a Novartis division, today announced the US FDA approval and launch of Glatopa ® (glatiramer acetate injection) 40 mg/mL. Glatopa ...
Finanznachrichten7y
Novartis International AG: Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Novartis International AG / Sandoz announces US FDA approval and launch of Glatopa 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis . Processed and transmitted ...